Envista (NYSE:NVST) Announces Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Envista (NYSE:NVST - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.24 EPS for the quarter, beating analysts' consensus estimates of $0.23 by $0.01, Zacks reports. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Stock Down 2.4 %

Shares of NYSE:NVST traded down $0.53 during trading hours on Friday, reaching $21.27. The stock had a trading volume of 2,438,400 shares, compared to its average volume of 2,268,009. The stock has a market capitalization of $3.66 billion, a price-to-earnings ratio of -3.28, a P/E/G ratio of 2.06 and a beta of 1.34. The firm's 50 day moving average is $19.94 and its 200-day moving average is $19.17. Envista has a 1 year low of $15.15 and a 1 year high of $23.06. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.77 and a current ratio of 2.04.

Wall Street Analysts Forecast Growth

NVST has been the subject of several research analyst reports. Mizuho assumed coverage on shares of Envista in a research note on Wednesday, December 4th. They set an "underperform" rating and a $20.00 target price for the company. Piper Sandler boosted their target price on Envista from $17.00 to $18.00 and gave the company a "neutral" rating in a research report on Monday, February 3rd. Needham & Company LLC restated a "hold" rating on shares of Envista in a research report on Thursday. Stifel Nicolaus boosted their price objective on Envista from $18.00 to $21.00 and gave the company a "buy" rating in a report on Wednesday, October 23rd. Finally, Wells Fargo & Company raised their target price on Envista from $20.00 to $21.00 and gave the company an "equal weight" rating in a report on Thursday. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $20.21.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.